Dirkjan J. Hijnen
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Serum Eosinophil-Derived Neurotoxin (EDN) as a Biomarker for Treatment Response in Atopic Dermatitis.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: December 31, 2025
Serum proteomic changes in atopic dermatitis patients treated with cyclosporine.
Journal: PloS one
Published: July 17, 2025
International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.
Journal: Journal of the American Academy of Dermatology
Published: June 30, 2025
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients.
Journal: Acta dermato-venereologica
Published: January 20, 2025
Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients.
Journal: Acta dermato-venereologica
Published: November 12, 2024
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 11, 2024
Methodological Considerations in PRP Treatment for Lichen Planopilaris: Addressing Potential Bias.
Journal: Journal of cosmetic dermatology
Published: October 25, 2024
Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice.
Journal: Acta dermato-venereologica
Published: September 05, 2024
Higher prevalence of dupilumab-induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis.
Journal: Clinical and translational allergy
Published: April 16, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
Journal: American journal of clinical dermatology
Published: February 08, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Journal: The Journal of allergy and clinical immunology
Published: December 23, 2023
Last Updated: 09/26/2026